Early Screening of Young COPD and Pre-COPD

Not yet recruitingOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

March 1, 2025

Primary Completion Date

December 30, 2026

Study Completion Date

December 30, 2026

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

Budesonide, Glycopyrronium Bromide and Formoterol Fumarate Inhalation Aerosol

The intervention group was given budigfovir once a day, the dose was 160ug/7.2ug/4.8ug by inhalation

All Listed Sponsors

lead

yanmengkang

OTHER

NCT06844175 - Early Screening of Young COPD and Pre-COPD | Biotech Hunter | Biotech Hunter